No name

Did you know that schizophrenia affects more than 1 percent of the world's population?

See NARSAD Grants at work on the latest schizophrenia research

Schizophrenia is a severe, chronic, and generally disabling brain and behavior disorder. It is most accurately described as a psychosis - a type of illness that causes severe mental disturbances that disrupt normal thoughts, speech, and behavior. Schizophrenia is believed to be caused by a combination of genetic and environmental factors.

Positive symptoms may include delusions, thought disorders, and hallucinations. People with schizophrenia may hear voices other people don't hear, or believe other people are reading their minds, controlling their thoughts, or plotting to harm them. Negative symptoms may include avolition (a lack of desire or motivation to accomplish goals), lack of desire to form social relationships, and blunted affect and emotion. Cognitive symptoms involve problems with attention and memory, especially in planning and organization to achieve a goal. Cognitive deficits are the most disabling for patients trying to lead a normal life.

learn more about schizophrenia

Visit the Schizophrenia Research Forum, fully sponsored by the Brain & Behavior Research Foundation—a virtual community of scientists collaborating in their quest for causes, improved treatments, and better understanding of schizophrenia.

Visit the Schizophrenia Research Forum for more information about research

 

Karen Lynnette Gamble, Ph.D., University of Alabama at Birmingham
Karen Lynnette Gamble, Ph.D.
April 18, 2012
Disruption of the circadian clock, the 24-hour cycle of waking and sleeping, can increase the risk of a range of illnesses and can exacerbate stress, anxiety...
Daniel S. Pine, MD
Daniel S. Pine, MD
April 18, 2012
Adolescent depression is a worldwide mental health problem that often goes unrecognized, misdiagnosed and/or untreated. An in-depth review of the status of...
Andrew Miller, M.D., Emory University Director of Psychiatric Oncology Winship Cancer Institute
Andrew Miller, M.D.
April 18, 2012
An important new development in psychiatry is the growing body of research pointing to the involvement of the immune system in brain and behavior disorders,...
Rachel G. Klein, Ph.D., Professor of Psychiatry NYU Child Study Center
Rachel G. Klein, Ph.D.
April 18, 2012
Founding Member of the Foundation Scientific Council Shares Insight from 33-year Cohort Study with Children: Adolescence is a difficult time for many young...
Paul E Holtzheimer, M.D., M.S.
Paul E Holtzheimer, M.D., M.S.
April 18, 2012
The first placebo-controlled trial to verify the effectiveness and safety of deep brain stimulation (DBS) as a treatment for severe, treatment-resistant...

Pages

Subscribe to